Chen C H, Ting C T, Lin S J, Hsu T L, Yin F C, Siu C O, Chou P, Wang S P, Chang M S
Division of Cardiology, Veterans General Hospital-Taipei, Shih-Pai, Taiwan, ROC.
Hypertension. 1995 May;25(5):1034-41. doi: 10.1161/01.hyp.25.5.1034.
We conducted this study to compare the effects of fosinopril versus atenolol on peripheral blood pressure, central arterial wave reflection, and left ventricular mass in a group of patients with essential hypertension. We conducted a double-blind, randomized trial of fosinopril and atenolol in 79 hypertensive patients (52 men, 27 women; mean age, 45.8 +/- 8.5 years; range, 30 to 68 years). Carotid pressure waveforms were recorded noninvasively by applanation tonometry with a Millar micromanometer-tipped probe. The extent of wave reflection was estimated by the augmentation index defined as the ratio of the amplitude of pressure wave above its systolic shoulder to the pulse pressure. The augmentation index, left ventricular mass index by two-dimensional echocardiography, and 24-hour ambulatory blood pressures were determined before and after 8 weeks of daily treatment with fosinopril (10 to 20 mg) or atenolol (50 to 100 mg) with or without diuretics and compared with those values in 79 normotensive control subjects. After 8 weeks of treatment, both drugs lowered 24-hour ambulatory peripheral systolic and diastolic pressures into the normal range to a similar extent (fosinopril, -18/-13 mm Hg; atenolol, -23/-17 mm Hg, both P = NS). On the other hand, whereas the elevated augmentation index in hypertensive patients compared with normotensive subjects (16 +/- 11% versus 10 +/- 8%) was completely normalized by fosinopril (-9.3 +/- 9.8%, P < or = .002), it was lowered by atenolol (-4.8 +/- 8.9%, P < .002) but to a significantly smaller extent (fosinopril versus atenolol effect, P = .04).(ABSTRACT TRUNCATED AT 250 WORDS)
我们开展本研究以比较福辛普利与阿替洛尔对一组原发性高血压患者外周血压、中心动脉波反射及左心室质量的影响。我们对79例高血压患者(52例男性,27例女性;平均年龄45.8±8.5岁;范围30至68岁)进行了福辛普利和阿替洛尔的双盲随机试验。使用带有Millar微压力计探头的压平式眼压计无创记录颈动脉压力波形。通过增强指数估计波反射程度,增强指数定义为压力波高于其收缩期肩部的幅度与脉压之比。在每日服用福辛普利(10至20 mg)或阿替洛尔(50至100 mg)加或不加利尿剂治疗8周前后,测定增强指数、二维超声心动图测定的左心室质量指数以及24小时动态血压,并与79例血压正常的对照受试者的值进行比较。治疗8周后,两种药物均将24小时动态外周收缩压和舒张压降低至正常范围,程度相似(福辛普利,-18/-13 mmHg;阿替洛尔,-23/-17 mmHg,两者P=无显著性差异)。另一方面,与血压正常的受试者相比,高血压患者升高的增强指数(16±11%对10±8%)被福辛普利完全恢复正常(-9.3±9.8%,P≤0.002),被阿替洛尔降低(-4.8±8.9%,P<0.002),但降低程度明显较小(福辛普利与阿替洛尔的效果比较,P=0.04)。(摘要截断于250字)